Welcome and Introduction to the IPC and SOLAPSO
Angela Londoño, MSc, MD, Colombia
Fernando Valenzuela, MD, Chile
Infections and Anti TNF
Fernando Valenzuela, MD, Chile
Infections and Anti ILs
Cristina Echeverría, MD, Argentina
TB and Psoriasis Treatments
Ricardo Romitii, MD, PhD, Brazil
Infections and New Small Molecules
Angela Londoño, MSc, MD, Colombia
Clinical Cases and LATAM Challenges – Panel Discussion
Giuliana Castro Vargas, MD, Peru
Enrique Loayza, MD, Ecuador
Closing Remarks
Angela Londoño, MSc, MD, Colombia
Fernando Valenzuela, MD, Chile
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.
